Leap Therapeutics (LPTX) Conference Call to discuss Updated Data from Part B of the DeFianCe Study Transcript

Leap Therapeutics (NASDAQ:LPTX) Conference Call to discuss Updated Data from Part B of the DeFianCe Study March 26, 2025 8:00 AM ET Company Participants Douglas Onsi - President and CEO Cyndi Sirard - Chief Medical Officer Jason Baum - Chief Scientific Officer Good morning. Welcome to the Leap Therapeutics Conference Call to discuss Updated Data from Part B of the DeFianCe Study. At this time, all participants are on a listen-only mode. After the speakers' presentation, there will be a question-answer sessi ...